Antiretroviral Effect of Lovastatin on HIV-1-Infected Individuals Without Highly Active Antiretroviral Therapy (HAART): A Phase-II Randomized Clinical Trial (RCT).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lovastatin (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- Acronyms LIVE
Most Recent Events
- 04 Oct 2011 Biomarkers information updated
- 28 Sep 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 28 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.